Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20051742HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS20022496HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44015404HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44023634HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44012773HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44041591HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44041670HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44051073HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44047171HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44047121HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TCGA Plot Options
Drug Information
GeneESR2
DrugBank IDDB06202
Drug NameLasofoxifene
Target IDBE0000792
UniProt IDQ92731
Regulation Typeagonist
PubMed IDs19519291
CitationsPeng J, Sengupta S, Jordan VC: Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Anticancer Agents Med Chem. 2009 Jun;9(5):481-99.
GroupsApproved; Investigational
Direct ClassificationPhenylnaphthalenes
SMILES[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL328190